Hugues Bultot, CEO

• Degree in Law, University of Louvain, Belgium
• Certificate in Criminology, Universidad del País Vasco, Spain
• International Management Program, CEDEP/INSEAD
• DES in Management, Solvay Business School, Belgium
• DES in Tax Management, ICHEC, Belgium

Hugues is a high-tech entrepreneur with a broad experience in the field of entrepreneurial and operational management within emerging companies. He spent 10 years in the private equity sector. During that time, he held several positions: CEO, investment manager, COO, advisor to academic institutions and founder of university spin-offs. The outstanding results he has achieved are due to his technical background, his strategic vision and his ability to make the right decisions in an uncertain business climate.

Jose Castillo, Chairman

• Degree in Chemical Engineering, ULB, Belgium
• PhD in Applied Sciences (organic chemistry), ULB, Belgium 
• Best Business Plan Award, Solvay Business School, Belgium

Jose is an inspired inventor with a broad R&D experience in university environments. In addition, he accumulated an extensive knowledge in Operations as he was the Head of Industrialisation in a large company in the field of biotechnology. He is renowned for his inventions and his innovation capabilities. It is worth mentioning that Jose is an expert in smooth management since he has always been able to guid people through every stage of a new project.

Nicolas Havelange, Business Development Director

• Master's degree in Chemical Engineering
• Master's degree in Molecular Biology and Biotechnology, ULB, Belgium

Nicolas has 10 years' experience in the red and white biotech sector. He gained substantial experience in the field of contract biomanufacturing as a Process Development Director and a Business Development Director at Henogen, a medium-sized CMO. He is an expert in fermentation (E.coli, P.pastoris and LIactis) in volumes up to 100 liters, cell culture and virus production in bioreactors up to 300 liters with different cell lines (CHO, MDCK, VERO, SF9, NS0) both in fed-batch and in perfusion systems. In addition, is has an extensive knowledge in downstream processing (chromatography and filtration), in development and in GMP production. He was responsible for teams of up to 20 scientists and technicians and he was in charge of projects worth several EURmillions.

Eric Mathieu, Bioprocess Development

• Master's degree in Chemistry and Biological Industries, Gembloux Agricultural University, Belgium

Eric joined Artelis in 2006, after gaining substantial experience both in people and process management in the manufacturing industry. He is a specialist in biotechnology process development, scale-up of cell-culture processes, manufacturing of injectable cGMP for human use, internal and external auditing and pre-approval inspection of cGMP in leading biotech and pharmaceutical companies. He spent four years as a Production Manager (Suite B) and Supervisor at Baxter Neuchatel (Switzerland), five years as a Scaling-up Supervisor at Glaxo Smithkline Rixensart (Belgium) and three years as a Quality and Production Representative at Villers Monopole (water and soft drinks manufacturing) in Villers-le-Gambon (Belgium).

Guillaume de Viron, Finance and Planning Officer

• Master’s degree in Commercial Engineering and Business Administration, Namur, Belgium

Guillaume joined Artelis in 2008 after a 5-year experience at Deloitte Consulting. He has accumulated extensive knowledge and skills in budget control, in post-merger integration, in cost model, etc. Before he joined Deloitte, he achieved several goals: he set up a “mini-company” while at university, he was an active member in several student activities, he was a consultant for business angels, etc. He has always been active in business and intends to run his own company in the future.

Matt Kremer, Business Development - North America

• Master’s degree in Business Administration, Temple, Philadelphia, PA

Matt has 18 years’ business development experience in the pharmaceutical and biotechnology industries, including clinical trials, pharmaceutics, drug delivery and technology development. Prior to joining Artelis, he was at Neose Technologies where he was responsible for commercializing a novel protein pegylation technology. While at Neose, he established a collaboration with BioGeneriX AG for the co-development of a long-acting protein therapeutic that is now in Phase II clinical trials.

Emilie Cornélus, Human Resources & Administration Officer

• Master's degree in Private Law, Université de Paris X, France
• DES in Public Law, Université de Bourgogne, France
• DES in Finance & HR, Université de Lille 1, France

Emilie joined Artelis as a Human Resources & Administration Officer. Her good knowledge in Law led her to start a professional career in the sector of public services and in a management consulting company. She worked on complex legal topics. After this fulfilling experience, she became Technical & Legal Advisor at UNCCAS, the National Union of Social Action Community Center. In 2005, her career was reorientated as she obtained a DES in Finance and HR Management. This is how she was able to manage up to 15 people in a Local Public Institution. Working at Artelis was a unique opportunity for this hard worker to face a new challenge in her career.

Pascale Berthet, Business Development - Europe

• Master’s degree in Biochemistry - Molecular Biology, Université J. Fourier, Grenoble, France
• Post-graduate certification in Biology & Commercialization Methods - a degree that focuses on Sales and on Biotechnology, Université J. Fourier, Grenoble, France

Pascale joined Artelis in May 2009 after a 10-year professional experience in the field of commercialization of consumables and laboratory equipment for molecular and cellular biology. She is in touch with key people both in the field of R&D in the pharmaceutical industry and in Europe bioproduction. It is worth mentioning that in the past, she gained substantial experience at Applied Biosystems Group since she worked there for several years. Prior to joining Artelis, she worked at The Automation Partnership (TAP) - a manufacturer of automated cell culture systems. While at TAP, she accumulated extensive knowledge about the technologies and took part in several product developments and launches, particularly in the field of cell therapy, which is an emerging market.

• 
• Hugues
• 
• Jose
• 
• Nicolas
• 
• Eric
• 
• 
• Matt
• 
• Emilie